Can the clinical outcome in stage II colon carcinomas be predicted by determination of molecular marker expression?

Fernández-Cebrián, J M; Nevado Santos, M; Vorwald Kuborn, P; Pardo de Lama, M; Martín-Cavanna, J; Pacheco Martínez, P; Fernández Escudero, B; Ramos Fernández, M

Fernández-Cebrián, J M; Nevado Santos, M; Vorwald Kuborn, P; Pardo de Lama, M; Martín-Cavanna, J; Pacheco Martínez, P; Fernández Escudero, B; Ramos Fernández, M.

Affiliation

Fernández-Cebrián JM; Division of Gastrointestinal Surgery. Fundación Hospital Alcorcón. University Rey Juan Carlos. Alcorcón. Madrid, Spain. jmfernandez@fhalcorcon.es

Clin Transl Oncol ; 9(10): 663-70, 2007 Oct.

Article in En | MEDLINE | ID: mdl-17974527

Subject(s)

Biomarkers, Tumor/analysis; Carcinoma/mortality; Colonic Neoplasms/mortality; Factor VIII/analysis; Ki-67 Antigen/analysis; Neoplasm Recurrence, Local/diagnosis; Aged; Aged, 80 and over; Carcinoma/pathology; Colonic Neoplasms/pathology; Disease-Free Survival; Female; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Prognosis

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Factor VIII / Carcinoma / Biomarkers, Tumor / Colonic Neoplasms / Ki-67 Antigen / Neoplasm Recurrence, Local Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Transl Oncol Year: 2007 Document type: Article Affiliation country: Spain Country of publication: Italy

Search on Google

Add to My VHL

XML

PubMed Links